Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial.

Julie FalardeauAllison FrymanRohan WanchuGail H MarracciMichele MassLindsey WooliscroftDennis N BourdetteCharles F MurchisonWilliam L HillsVijayshree Yadav

Published in: Multiple sclerosis journal - experimental, translational and clinical (2019)

Six weeks of oral lipoic acid supplementation after acute optic neuritis is safe and well tolerated; however, because of insufficient recruitment, we could not conclude that lipoic acid treatment was neuroprotective in acute optic neuritis.

Keyphrases

liver failure
optical coherence tomography
placebo controlled
respiratory failure
randomized controlled trial
drug induced
clinical trial
aortic dissection
radiation therapy
hepatitis b virus
brain injury
combination therapy
gestational age
phase iii